SCHEMBL5486291

SCHEMBL5486291

CC(=O)OC(C)c1[c]ccc([N+](=O)[O-])c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
SMN1; SMN2 Q16637 6/20 0.36
LMNA P02545 4/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GLO1 Q04760 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
RECQL P46063 1/20 0.34
CYP1A2 P05177 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5742335 0.82 LMNA (0.40) ALDH1A1SMN1; SMN2LMNAKDM4EHTT
SCHEMBL10914343 0.79 TSHR (0.39) ALDH1A1SMN1; SMN2LMNAMAPK1KDM4E
SCHEMBL10914346 0.79 TSHR (0.39) ALDH1A1SMN1; SMN2LMNAMAPK1KDM4E
SCHEMBL4390254 0.78 TSHR (0.42) ALDH1A1SMN1; SMN2LMNAHPGDHTT
SCHEMBL2298630 0.75 TSHR (0.39) ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL10061896 0.72 MAPT (0.47) ALDH1A1SMN1; SMN2LMNAPOLBMAPK1
SCHEMBL27736702 0.72 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2LMNAMAPK1KDM4E
SCHEMBL8760108 0.72 MAPT (0.51) ALDH1A1MAPK1KDM4EMAPTHPGD
SCHEMBL27468094 0.72 MAPT (0.51) ALDH1A1MAPK1KDM4EMAPTHPGD
SCHEMBL28850127 0.72 TSHR (0.42) ALDH1A1SMN1; SMN2LMNAMAPK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242059-B1 NOVEL PRODRUGS FOR ANTIMICROBIAL AMIDINES UNIV NORTH CAROLINA (US) 2007-03-21 EP claimed
WO-2001062242-A1 PRODRUGS OF SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2001-08-30 WO disclosed